Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,134.87,01/06/2015,GNRL,255043352
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,119.05,10/29/2013,GNRL,23817202
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,115.00,04/22/2014,GNRL,156739520
353542,GNRL,"Astellas Pharma US Inc",IL,100000000137,106.12,09/30/2015,GNRL,295017850
353542,GNRL,"AbbVie, Inc.",IL,100000000204,99.88,08/28/2014,GNRL,189477960
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,95.96,04/20/2015,GNRL,337461688
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,86.25,04/22/2014,GNRL,156739518
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,82.66,10/02/2013,GNRL,13982492
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,69.00,01/22/2015,GNRL,336835704
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,65.17,03/11/2015,GNRL,255310506
353542,GNRL,"Amgen Inc.",CA,100000000203,59.96,09/28/2015,GNRL,297808440
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,52.55,03/27/2014,GNRL,201427440
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,47.75,02/11/2014,GNRL,150636838
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,29.95,12/11/2015,GNRL,275693446
353542,GNRL,"Takeda Pharmaceuticals U.S.A., Inc.",IL,100000000337,27.28,05/14/2014,GNRL,194664110
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,21.69,10/16/2015,GNRL,290256152
353542,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,20.94,08/01/2014,GNRL,158683730
353542,GNRL,"Pfizer Inc.",NY,100000000286,20.63,10/18/2013,GNRL,205649362
353542,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,20.23,05/19/2014,GNRL,221151118
353542,GNRL,"Iroko Pharmaceuticals, LLC",PA,100000011114,19.87,04/29/2014,GNRL,227837150
353542,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,19.74,09/27/2013,GNRL,24122938
353542,GNRL,"Novo Nordisk Inc",NJ,100000000144,19.73,08/20/2015,GNRL,267003162
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,19.34,01/09/2015,GNRL,336829746
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.17,07/11/2014,GNRL,196124088
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.89,06/30/2015,GNRL,290256156
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.88,06/26/2014,GNRL,150432654
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,18.61,09/06/2013,GNRL,100447772
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,18.09,11/21/2013,GNRL,100447762
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.72,06/24/2014,GNRL,196124090
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,17.69,03/06/2014,GNRL,199571730
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.56,04/07/2015,GNRL,254967546
353542,GNRL,"LILLY USA, LLC",IN,100000000066,17.41,01/23/2014,GNRL,137785704
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.40,04/10/2014,GNRL,194664121
353542,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.34,08/09/2013,GNRL,24122940
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.95,09/11/2013,GNRL,103323164
353542,GNRL,"AbbVie, Inc.",IL,100000000204,16.92,04/07/2014,GNRL,189256706
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16.80,09/04/2015,GNRL,319825926
353542,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,16.52,05/20/2014,GNRL,158566476
353542,GNRL,"Amgen Inc.",CA,100000000203,16.50,12/11/2014,GNRL,138220670
353542,GNRL,"Pfizer Inc.",NY,100000000286,16.29,12/13/2013,GNRL,205460962
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,16.29,05/14/2015,GNRL,330528871
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.28,05/07/2015,GNRL,337147848
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,16.00,02/18/2015,GNRL,339567358
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,15.91,08/08/2013,GNRL,100859778
353542,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,15.84,12/24/2013,GNRL,24122939
353542,GNRL,"Amgen Inc.",CA,100000000203,15.79,10/30/2015,GNRL,297808438
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,15.76,04/03/2014,GNRL,147756134
353542,GNRL,"Pfizer Inc.",NY,100000000286,15.69,09/17/2015,GNRL,323271130
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,15.57,08/21/2015,GNRL,337324734
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.54,06/09/2014,GNRL,149893528
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,15.44,10/24/2013,GNRL,100447770
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.42,11/15/2013,GNRL,12112785
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.31,01/27/2015,GNRL,254913963
353542,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.92,02/24/2014,GNRL,197890718
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,14.66,02/21/2014,GNRL,147756096
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,14.56,05/22/2014,GNRL,201793490
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.26,01/22/2015,GNRL,336832646
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,13.69,08/15/2013,GNRL,100447760
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.67,04/10/2015,GNRL,256404016
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.61,10/09/2015,GNRL,337372576
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,13.60,02/14/2014,GNRL,199571728
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.52,09/23/2013,GNRL,103323162
353542,GNRL,"Amgen Inc.",CA,100000000203,13.51,03/26/2015,GNRL,297808432
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.50,11/22/2013,GNRL,103323160
353542,GNRL,"Pfizer Inc.",NY,100000000286,13.50,12/03/2013,GNRL,206059446
353542,GNRL,"Lilly USA, LLC",IN,100000000066,13.41,05/19/2015,GNRL,268107098
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.38,09/17/2013,GNRL,13982491
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.37,12/07/2015,GNRL,255842360
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.36,10/04/2013,GNRL,104382162
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.36,12/09/2014,GNRL,194664108
353542,GNRL,"Amgen Inc.",CA,100000000203,13.35,06/02/2015,GNRL,297808428
353542,GNRL,"Lilly USA, LLC",IN,100000000066,13.20,07/24/2015,GNRL,268107062
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.11,06/09/2015,GNRL,290256158
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.10,08/27/2015,GNRL,337310694
353542,GNRL,"Amgen Inc.",CA,100000000203,13.07,09/25/2015,GNRL,297808436
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.04,03/27/2015,GNRL,256256152
353542,GNRL,"LILLY USA, LLC",IN,100000000066,12.91,02/10/2014,GNRL,137837336
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.89,06/23/2014,GNRL,194664126
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.88,06/01/2015,GNRL,339374220
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.87,03/07/2014,GNRL,148293906
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.87,10/08/2015,GNRL,255472386
353542,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.86,01/20/2014,GNRL,160750960
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.76,09/12/2013,GNRL,104371132
353542,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.64,01/14/2014,GNRL,152432628
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.63,08/11/2014,GNRL,147756158
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.61,01/03/2014,GNRL,156739500
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.59,12/05/2013,GNRL,14042938
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,12.58,12/14/2015,GNRL,331153111
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.54,10/31/2014,GNRL,194664104
353542,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,12.54,08/19/2015,GNRL,293918880
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.48,11/08/2013,GNRL,103323158
353542,GNRL,"LILLY USA, LLC",IN,100000000066,12.45,07/07/2014,GNRL,137800674
353542,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.41,10/26/2015,GNRL,320041260
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.40,08/27/2015,GNRL,256274648
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.36,11/25/2014,GNRL,156739508
353542,GNRL,"Pfizer Inc.",NY,100000000286,12.36,04/16/2015,GNRL,322385506
353542,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.35,11/10/2014,GNRL,197890714
353542,GNRL,"Lilly USA, LLC",IN,100000000066,12.34,02/06/2015,GNRL,268107070
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.31,03/20/2015,GNRL,290256160
353542,GNRL,"Pfizer Inc.",NY,100000000286,12.30,12/09/2013,GNRL,205994272
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.28,10/15/2015,GNRL,275693448
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,12.27,05/01/2014,GNRL,199571725
353542,GNRL,"Purdue Pharma L.P.",CT,100000005432,12.25,04/28/2015,GNRL,251072680
353542,GNRL,"LILLY USA, LLC",IN,100000000066,12.23,02/18/2014,GNRL,137726058
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.21,03/04/2014,GNRL,188611460
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.09,07/14/2014,GNRL,188668350
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.08,12/19/2014,GNRL,148851826
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.08,05/09/2014,GNRL,194664096
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.06,03/13/2014,GNRL,194664088
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.04,10/17/2014,GNRL,196124086
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.01,05/13/2014,GNRL,194664092
353542,GNRL,"Endo Pharmaceuticals Inc.",PA,100000000285,12.01,09/01/2015,GNRL,338842162
353542,GNRL,"Amgen Inc.",CA,100000000203,12.00,05/08/2014,GNRL,138220668
353542,GNRL,"Pfizer Inc.",NY,100000000286,11.97,08/29/2013,GNRL,205326400
353542,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.96,01/30/2015,GNRL,266091576
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.96,10/23/2015,GNRL,339303528
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.96,10/23/2015,GNRL,339303534
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.95,08/29/2014,GNRL,188745742
353542,GNRL,"Pfizer Inc.",NY,100000000286,11.95,03/20/2014,GNRL,206613932
353542,GNRL,"Santarus, Inc",NC,100000010767,11.93,11/05/2013,GNRL,103657744
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.90,11/19/2013,GNRL,14271553
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.86,04/03/2015,GNRL,325949750
353542,GNRL,"LILLY USA, LLC",IN,100000000066,11.85,03/24/2014,GNRL,137726046
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.85,09/11/2015,GNRL,330930489
353542,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.82,03/30/2015,GNRL,320041248
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.82,03/06/2015,GNRL,339283450
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.73,12/19/2014,GNRL,148380762
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.70,09/20/2013,GNRL,171867804
353542,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,11.68,11/11/2013,GNRL,21846136
353542,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,11.67,05/27/2014,GNRL,217674636
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.67,07/18/2014,GNRL,194664124
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.64,10/10/2014,GNRL,194664118
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.63,08/11/2014,GNRL,147756130
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.61,01/02/2014,GNRL,196124094
353542,GNRL,"Alcon Laboratories Inc",TX,100000005405,11.61,04/14/2015,GNRL,315059936
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.57,03/31/2014,GNRL,201781874
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.57,10/19/2015,GNRL,339262944
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.56,12/10/2013,GNRL,100859780
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.56,10/31/2013,GNRL,14271370
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.56,11/04/2014,GNRL,202487712
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.52,03/14/2014,GNRL,196124092
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.51,10/10/2013,GNRL,23817204
353542,GNRL,"Amgen Inc.",CA,100000000203,11.47,12/20/2013,GNRL,8983397
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.47,12/23/2014,GNRL,196020416
353542,GNRL,"Lilly USA, LLC",IN,100000000066,11.47,10/13/2015,GNRL,268107102
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.44,12/19/2013,GNRL,100787744
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.44,09/13/2013,GNRL,103323168
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.43,01/21/2014,GNRL,187733150
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.40,07/29/2014,GNRL,188721690
353542,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.37,12/18/2014,GNRL,199571722
353542,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.37,06/04/2015,GNRL,320041254
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.34,09/21/2015,GNRL,255765598
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.30,10/02/2014,GNRL,149045936
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.28,03/02/2015,GNRL,339240184
353542,GNRL,"Purdue Pharma L.P.",CT,100000005432,11.27,01/15/2015,GNRL,251059154
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.27,10/29/2015,GNRL,290256150
353542,GNRL,"Auxilium Pharmaceuticals, Inc.",PA,100000010522,11.23,05/02/2014,GNRL,212070530
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.22,06/10/2014,GNRL,188648666
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.22,01/20/2015,GNRL,339236222
353542,GNRL,"Lilly USA, LLC",IN,100000000066,11.20,11/17/2015,GNRL,268107096
353542,GNRL,"Pfizer Inc.",NY,100000000286,11.19,09/03/2013,GNRL,205085756
353542,GNRL,"Amgen Inc.",CA,100000000203,11.11,10/12/2015,GNRL,297808430
353542,GNRL,"Pfizer Inc.",NY,100000000286,11.11,03/23/2015,GNRL,322990552
353542,GNRL,"Pfizer Inc.",NY,100000000286,11.10,07/17/2014,GNRL,206617650
353542,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,11.07,11/12/2013,GNRL,24122937
353542,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.06,11/18/2014,GNRL,162238048
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.05,11/19/2015,GNRL,331060473
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.03,10/17/2013,GNRL,14297559
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.02,11/04/2013,GNRL,12258048
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.02,04/21/2014,GNRL,156739504
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.00,06/12/2014,GNRL,150941362
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.96,02/11/2014,GNRL,148467716
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.91,11/01/2013,GNRL,104333248
353542,GNRL,"Pfizer Inc.",NY,100000000286,10.91,10/03/2013,GNRL,205860674
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.86,02/17/2015,GNRL,336877662
353542,GNRL,"Lilly USA, LLC",IN,100000000066,10.85,08/04/2015,GNRL,268107080
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.83,10/09/2014,GNRL,148417432
353542,GNRL,"LILLY USA, LLC",IN,100000000066,10.78,10/13/2014,GNRL,137859354
353542,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.66,08/31/2015,GNRL,290256154
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.62,08/27/2013,GNRL,14012052
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.60,03/03/2014,GNRL,187790994
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.59,06/12/2014,GNRL,150945802
353542,GNRL,"Shionogi Inc",NJ,100000005589,10.58,03/12/2015,GNRL,294499720
353542,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,10.58,04/11/2015,GNRL,326835204
353542,GNRL,"Santarus, Inc",NC,100000010767,10.50,08/26/2013,GNRL,103657742
353542,GNRL,"Amgen Inc.",CA,100000000203,10.50,10/08/2013,GNRL,8983396
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.49,09/30/2013,GNRL,12100353
353542,GNRL,"Lilly USA, LLC",IN,100000000066,10.49,06/22/2015,GNRL,268107066
353542,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.48,08/06/2013,GNRL,111756724
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.47,11/18/2013,GNRL,6785238
353542,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.47,07/15/2014,GNRL,197890716
353542,GNRL,"Pfizer Inc.",NY,100000000286,10.46,05/21/2015,GNRL,323471254
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.44,02/20/2014,GNRL,201813904
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.28,05/01/2015,GNRL,255521764
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.28,05/15/2015,GNRL,337134026
353542,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.27,01/17/2014,GNRL,149687082
353542,GNRL,"Amgen Inc.",CA,100000000203,10.24,01/29/2015,GNRL,297808442
353542,GNRL,"Pfizer Inc.",NY,100000000286,10.22,10/01/2015,GNRL,323280534
353542,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.20,06/13/2014,GNRL,161435214
353542,GNRL,"LILLY USA, LLC",IN,100000000066,10.18,04/24/2014,GNRL,137627678
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.10,11/07/2014,GNRL,194664114
353542,GNRL,"Pfizer Inc.",NY,100000000286,10.09,08/13/2013,GNRL,205162610
353542,GNRL,"Pfizer Inc.",NY,100000000286,10.08,09/03/2015,GNRL,323809798
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.06,03/18/2014,GNRL,147756104
353542,GNRL,"LILLY USA, LLC",IN,100000000066,10.00,09/16/2013,GNRL,4758399
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.98,08/16/2013,GNRL,23817203
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.98,10/23/2015,GNRL,339143060
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.98,10/23/2015,GNRL,339143062
353542,GNRL,"Pfizer Inc.",NY,100000000286,9.97,02/13/2015,GNRL,323083894
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.90,06/27/2014,GNRL,188696450
353542,GNRL,"Pfizer Inc.",NY,100000000286,9.88,02/03/2015,GNRL,322331583
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.85,07/01/2014,GNRL,201825580
353542,GNRL,"Pfizer Inc.",NY,100000000286,9.75,06/12/2015,GNRL,322999428
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.70,02/24/2014,GNRL,147756100
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.66,06/16/2015,GNRL,330621679
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.50,06/26/2015,GNRL,339128390
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.37,09/15/2015,GNRL,330982267
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.32,02/16/2015,GNRL,339123082
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.09,03/17/2014,GNRL,156739512
353542,GNRL,"Astellas Pharma US Inc",IL,100000000137,9.09,08/11/2015,GNRL,294990298
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.08,01/19/2015,GNRL,336830136
353542,GNRL,"LILLY USA, LLC",IN,100000000066,9.03,01/07/2014,GNRL,137573480
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.01,04/22/2014,GNRL,201783546
353542,GNRL,"LILLY USA, LLC",IN,100000000066,9.00,05/20/2014,GNRL,137679446
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.87,11/25/2014,GNRL,202506430
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.81,09/18/2015,GNRL,337340722
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.76,05/06/2014,GNRL,147756154
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.75,10/27/2015,GNRL,339098240
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.72,01/06/2014,GNRL,194664112
353542,GNRL,"LILLY USA, LLC",IN,100000000066,8.62,07/31/2014,GNRL,137759068
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.62,10/06/2015,GNRL,331000319
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.57,06/30/2014,GNRL,147756126
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.51,04/20/2015,GNRL,330446110
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,8.30,12/08/2014,GNRL,188868422
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.29,11/03/2014,GNRL,202375852
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.29,08/03/2015,GNRL,339084930
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.05,04/08/2014,GNRL,201476720
353542,GNRL,"Amgen Inc.",CA,100000000203,7.95,05/22/2015,GNRL,297808434
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.86,11/03/2015,GNRL,331189125
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.81,08/30/2013,GNRL,100447768
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.81,06/01/2015,GNRL,339072122
353542,GNRL,"Astellas Pharma US Inc",IL,100000000137,7.72,11/16/2015,GNRL,295068404
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.72,02/12/2015,GNRL,331203189
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,7.62,06/16/2014,GNRL,188734678
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,7.62,10/27/2014,GNRL,188879018
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.61,08/28/2014,GNRL,194664100
353542,GNRL,"LILLY USA, LLC",IN,100000000066,7.59,10/29/2013,GNRL,4693889
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.58,10/07/2013,GNRL,100447758
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.54,12/01/2015,GNRL,339065498
353542,GNRL,"Lilly USA, LLC",IN,100000000066,7.50,03/31/2015,GNRL,268107074
353542,GNRL,"Lilly USA, LLC",IN,100000000066,7.47,12/19/2015,GNRL,268107094
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,7.46,11/07/2013,GNRL,13982489
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.38,02/19/2015,GNRL,337055348
353542,GNRL,"Lilly USA, LLC",IN,100000000066,7.34,02/05/2015,GNRL,268107088
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,7.16,08/08/2014,GNRL,156739516
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.14,06/05/2015,GNRL,339055612
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.08,04/30/2015,GNRL,339054218
353542,GNRL,"Lilly USA, LLC",IN,100000000066,7.04,05/18/2015,GNRL,268107086
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.99,08/13/2015,GNRL,330762093
353542,GNRL,"Lilly USA, LLC",IN,100000000066,6.98,06/23/2015,GNRL,268107090
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,6.92,04/11/2014,GNRL,147756166
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.92,10/06/2014,GNRL,194664130
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.90,04/01/2014,GNRL,188571624
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.87,01/05/2015,GNRL,336829926
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.81,09/29/2014,GNRL,202795014
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.75,05/12/2015,GNRL,339044906
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.56,08/03/2015,GNRL,339040172
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.45,01/12/2015,GNRL,339037548
353542,GNRL,"Pfizer Inc.",NY,100000000286,6.37,09/03/2013,GNRL,205619260
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,6.35,12/16/2013,GNRL,23817206
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,6.35,01/24/2014,GNRL,156739510
353542,GNRL,"Lilly USA, LLC",IN,100000000066,6.35,04/09/2015,GNRL,268107072
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.33,04/10/2015,GNRL,339034876
353542,GNRL,"LILLY USA, LLC",IN,100000000066,6.28,11/25/2013,GNRL,4715796
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.24,05/08/2015,GNRL,339032860
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.00,02/16/2015,GNRL,339027068
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,5.97,06/15/2015,GNRL,339026076
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.93,10/01/2013,GNRL,100447766
353542,GNRL,"Lilly USA, LLC",IN,100000000066,5.86,03/05/2015,GNRL,268107068
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,5.78,11/20/2015,GNRL,339021430
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.77,08/05/2013,GNRL,100447764
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.77,07/08/2014,GNRL,147756122
353542,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,5.59,07/22/2014,GNRL,188672098
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.43,12/06/2013,GNRL,23817205
353542,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.39,01/26/2015,GNRL,330397085
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.27,07/28/2014,GNRL,156739514
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,5.19,10/07/2015,GNRL,339007402
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.86,05/08/2015,GNRL,338998132
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.81,05/01/2015,GNRL,338996994
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,4.50,01/09/2014,GNRL,147756108
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,4.28,07/25/2014,GNRL,147756150
353542,GNRL,"Lilly USA, LLC",IN,100000000066,4.13,11/30/2015,GNRL,268107084
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,3.97,05/28/2015,GNRL,338975498
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.93,02/13/2014,GNRL,147756093
353542,GNRL,"LILLY USA, LLC",IN,100000000066,3.70,05/20/2014,GNRL,137778144
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.50,11/20/2014,GNRL,147756142
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.39,02/18/2014,GNRL,147756088
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,3.35,07/07/2015,GNRL,338958790
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.33,04/15/2014,GNRL,147756138
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3.00,09/17/2013,GNRL,13982490
353542,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,2.76,09/10/2013,GNRL,103323166
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,2.63,01/03/2014,GNRL,156739502
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.43,02/16/2015,GNRL,338911656
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.40,04/10/2014,GNRL,147756162
353542,GNRL,"Pfizer Inc.",NY,100000000286,2.39,10/01/2015,GNRL,322858010
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.35,08/28/2015,GNRL,338905975
353542,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,2.30,12/05/2013,GNRL,14042937
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.19,07/25/2014,GNRL,147756116
353542,GNRL,"Lilly USA, LLC",IN,100000000066,2.02,07/24/2015,GNRL,268107064
353542,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,2.01,04/21/2014,GNRL,156739506
353542,GNRL,"Lilly USA, LLC",IN,100000000066,1.95,11/30/2015,GNRL,268107082
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.95,05/21/2015,GNRL,323115096
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.90,02/03/2015,GNRL,323078964
353542,GNRL,"LILLY USA, LLC",IN,100000000066,1.87,02/10/2014,GNRL,137754842
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.82,12/13/2013,GNRL,205556098
353542,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.78,12/09/2014,GNRL,147756113
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.73,09/17/2015,GNRL,323266850
353542,GNRL,"LILLY USA, LLC",IN,100000000066,1.72,05/20/2014,GNRL,137755462
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.67,02/13/2015,GNRL,323783590
353542,GNRL,"Lilly USA, LLC",IN,100000000066,1.64,05/18/2015,GNRL,268107076
353542,GNRL,"Lilly USA, LLC",IN,100000000066,1.64,08/04/2015,GNRL,268107078
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.57,10/18/2013,GNRL,205752524
353542,GNRL,"LILLY USA, LLC",IN,100000000066,1.50,09/16/2013,GNRL,4764117
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.47,06/05/2015,GNRL,338882584
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.31,12/01/2015,GNRL,338879676
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.23,12/03/2013,GNRL,205978938
353542,GNRL,"Pfizer Inc.",NY,100000000286,1.23,10/03/2013,GNRL,205852881
353542,GNRL,"Lilly USA, LLC",IN,100000000066,0.98,12/19/2015,GNRL,268107092
353542,GNRL,"Lilly USA, LLC",IN,100000000066,0.98,05/19/2015,GNRL,268107100
353542,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.98,01/12/2015,GNRL,338873550
353542,GNRL,"Pfizer Inc.",NY,100000000286,0.92,08/29/2013,GNRL,205155990
353542,GNRL,"Pfizer Inc.",NY,100000000286,0.92,08/13/2013,GNRL,205324568
353542,GNRL,"Pfizer Inc.",NY,100000000286,0.16,07/15/2015,GNRL,323737138
